Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance
2023 · Nature Communications · 61 citations
https://doi.org/10.1038/s41467-023-35995-2
R
Rui You
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
78
Papers
2.8K
Citations
27
h-index
44
i10-index
Rui You is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Head and Neck Cancer Studies & Head and Neck Surgical Oncology & Lung Cancer Research Studies. The author has an h-index of 27, co-authored 67 publications.
ORCID: 0000-0001-9362-8144Papers by this author
worksThe long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis
2019 · BMC Cancer · 41 citations
https://doi.org/10.1186/s12885-019-6156-5
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial
2023 · Cell Reports Medicine · 22 citations
https://doi.org/10.1016/j.xcrm.2023.101279
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 study
2023 · EClinicalMedicine · 17 citations
https://doi.org/10.1016/j.eclinm.2023.102043
<i>Lachnoclostridium</i> intestinal flora is associated with immunotherapy efficacy in nasopharyngeal carcinoma
2024 · Head & Neck · 7 citations
https://doi.org/10.1002/hed.27917
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinoma
2024 · Cell Reports Medicine · 6 citations
https://doi.org/10.1016/j.xcrm.2024.101779
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat